Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells

Epithelial-mesenchymal transition (EMT), a process closely related to tumor development, is regulated by a variety of signaling pathways and growth factors, such as transforming growth factor-β1 (TGF-β1) and epidermal growth factor (EGF). Hyaluronan (HA) has been shown to induce EMT through either TGF-β1 or EGF signaling and to be a regulator of the crosstalk between these two pathways in fibroblasts. In this study, in order to clarify whether HA has the same effect in tumor cells, we utilized the lung cancer cell line, A549, and the breast cancer cell line, MCF-7, and found that the effects of stimulation with TGF-β1 were more potent than those of EGF in regulating the expression of EMT-associated proteins and in enhancing cell migration and invasion. In addition, we observed that TGF-β1 activated EGF receptor (EGFR) and its downstream AKT and extracellular signal-regulated kinase (ERK) pathways. Furthermore, we found that TGF-β1 upregulated the expression of hyaluronan synthases (HAS1, HAS2 and HAS3) and promoted the expression of CD44, a cell surface receptor for HA, which interacts with EGFR, resulting in the activation of the downstream AKT and ERK pathways. Conversely, treatment with 4-methylumbelliferone (4-MU; an inhibitor of HAS) prior to stimulation with TGF-β1, inhibited the expression of CD44 and EGFR, abolished the interaction between CD44 and EGFR. Furthermore, the use of shRNA targeting CD44 impaired the expression of EGFR, deactivated the AKT and ERK pathways, reversed EMT and decreased the migration and invasion ability of cells. In conclusion, our data demonstrate that TGF-β1 induces EMT by the transactivation of EGF signaling through HA/CD44 in lung and breast cancer cells.

[1]  M. Korc,et al.  Erratum: microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions , 2014, Oncogene.

[2]  Guotong Xu,et al.  Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR , 2014, International Journal of Cancer.

[3]  Q. Tong,et al.  Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. , 2014, World journal of gastroenterology.

[4]  Tao Wang,et al.  Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer , 2014, Journal of experimental & clinical cancer research : CR.

[5]  A. Berndt,et al.  Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells. , 2014, Experimental cell research.

[6]  Yong He,et al.  Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal , 2014, Clinical Cancer Research.

[7]  Zhidong Liu,et al.  Correlation Between Expression of Cell Adhesion Molecules CD 44 v6 and E-cadherin and Lymphatic Metastasis in Non- small Cell Lung Cancer , 2014 .

[8]  A. Phillips,et al.  MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts , 2013, Aging cell.

[9]  M. Lazzara,et al.  ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. , 2014, Cancer research.

[10]  Zhidong Liu,et al.  Correlation Between Expression of Cell Adhesion Molecules CD 44 v 6 and E-cadherin and Lymphatic Metastasis in Non-small Cell Lung Cancer , 2014 .

[11]  Andrew H. Beck,et al.  The Adherens Junction Protein Afadin Is an AKT Substrate that Regulates Breast Cancer Cell Migration , 2013, Molecular Cancer Research.

[12]  T. Tan,et al.  EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway , 2013, PloS one.

[13]  J. Hanaoka,et al.  Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition. , 2013, Oncology reports.

[14]  B. Toole,et al.  CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness* , 2013, The Journal of Biological Chemistry.

[15]  P. Mandal,et al.  Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells , 2013, Clinical & Experimental Metastasis.

[16]  Song Liu,et al.  FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes. , 2013, Anti-cancer agents in medicinal chemistry.

[17]  Hiroaki Nakamura,et al.  Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. , 2013, Cancer research.

[18]  A. Phillips,et al.  Transforming Growth Factor-β1 (TGF-β1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid Rafts* , 2013, The Journal of Biological Chemistry.

[19]  K. Carraway,et al.  CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. , 2013, Oral oncology.

[20]  Premkumar Vummidi Giridhar,et al.  CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches , 2013, Experimental biology and medicine.

[21]  N. Johnson,et al.  Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts , 2013, Clinical & Experimental Metastasis.

[22]  Y. Shang,et al.  Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. , 2013, Experimental cell research.

[23]  E. Raso,et al.  Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression , 2013, PloS one.

[24]  B. Cieply,et al.  Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis , 2013, Journal of Cell Science.

[25]  C. Heldin,et al.  Efficient TGFβ-induced epithelial–mesenchymal transition depends on hyaluronan synthase HAS2 , 2012, Oncogene.

[26]  R. Nicholson,et al.  Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan , 2012, BMC Cancer.

[27]  Desma M. Grice,et al.  Non-Stimulated, Agonist-Stimulated and Store-Operated Ca2+ Influx in MDA-MB-468 Breast Cancer Cells and the Effect of EGF-Induced EMT on Calcium Entry , 2012, PloS one.

[28]  Jung Weon Lee,et al.  Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. , 2012, The Biochemical journal.

[29]  J. Long,et al.  JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells , 2012, Tumor Biology.

[30]  S. Thomson,et al.  Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model , 2011, Clinical & Experimental Metastasis.

[31]  H. Kosmehl,et al.  EGF/TGFβ1 co-stimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[32]  S. Davidge,et al.  TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells. , 2010, Biochemical and biophysical research communications.

[33]  Michael K. Wendt,et al.  Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition Facilitates Epidermal Growth Factor-Dependent Breast Cancer Progression , 2010, Oncogene.

[34]  J. Mulshine,et al.  Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer , 2010, Journal of biomedicine & biotechnology.

[35]  A. Phillips,et al.  Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. , 2007, Experimental cell research.

[36]  A. Phillips,et al.  Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. , 2007, Experimental cell research.

[37]  P. Sharp,et al.  A positive feedback loop couples Ras activation and CD44 alternative splicing. , 2006, Genes & development.

[38]  S. Goodison,et al.  CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.

[39]  S. Toda,et al.  Transforming Growth Factor-β1 Induces a Mesenchyme-Like Cell Shape without Epithelial Polarization in Thyrocytes and Inhibits Thyroid Folliculogenesis in Collagen Gel Culture. , 1997, Endocrinology.